From Agadez to Zinder: Estimating coverage of the MenAfriVac™ conjugate vaccine against meningococcal serogroup A in Niger, September 2010 - January 2012

Vaccine

Volumn 31, Issue 12, 2013, Pages 1597-1603

  Caini, Saverio ^a,b   Beck, Nam Seon ^c   Yacouba, Harouna ^d   Maiga, Idrissa ^d   Chaibou, Ibrahim ^d   Hinsa, Ide ^d   Adakal, Aboubacar ^d   Issoufou, Aboubacar ^d   Kim, Sung Hye ^c   Pezzoli, Lorenzo ^c  

^a EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^b NATIONAL CENTER FOR EPIDEMIOLOGY   (Hungary)

^c International Vaccine Institute   (South Korea)

^d Ministry of Public Health   (Niger)

Author keywords

Cluster sampling; Lot quality assurance sampling; MenAfriVac ; Meningococcal meningitis serogroup A; Survey; Vaccination coverage

Indexed keywords

MENINGOCOCCUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONFIDENCE INTERVAL; FEMALE; HUMAN; INFANT; LOT QUALITY ASSURANCE SAMPLING; MALE; MENINGITIS; NIGER; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; VACCINATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; INFANT; MALE; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS, SEROGROUP A; NIGER; VACCINES, CONJUGATE; YOUNG ADULT;

EID: 84875256975     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.01.015     Document Type: Article

References (35)

1. Molesworth A.M., Thomson M.C., Connor S.J., Cresswell M.P., Morse A.P., Shears P., et al. Where is the meningitis belt? Defining an area at risk of epidemic meningitis in Africa. Trans R Soc Trop Med Hyg 2002, 96(May (3)):242-249.
2. Trotter C.L., Greenwood B.M. Meningococcal carriage in the African meningitis belt. Lancet Infect Dis 2007, 7(December (12)):797-803.
3. Yaka P., Sultan B., Broutin H., Janicot S., Philippon S., Fourquet N. Relationships between climate and year-to-year variability in meningitis outbreaks: a case study in Burkina Faso and Niger. Int J Health Geogr 2008, 7:34.
4. Sultan B., Labadi K., Guegan J.F., Janicot S. Climate drives the meningitis epidemics onset in West Africa. PLoS Med 2005, 2(January (1)):e6.
5. World Health Organization Meningitis in Burkina Faso, Chad, Niger, Nigeria and Ghana: 2010 epidemic season. Wkly Epidemiol Rec 2011, 86(April (15)):143-151.
6. Collard J.M., Maman Z., Yacouba H., Djibo S., Nicolas P., Jusot J.F., et al. Increase in Neisseria meningitidis serogroup W135, Niger, 2010. Emerg Infect Dis 2010, 16(September (9)):1496-1498.
7. Woods C.W., Armstrong G., Sackey S.O., Tetteh C., Bugri S., Perkins B.A., et al. Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa. Lancet 2000, 355(January (9197)):30-33.
8. Gasparini R., Panatto D. Meningococcal glycoconjugate vaccines. Hum Vaccin 2011, 7(February (2)):170-182.
9. Meningococcal vaccines: WHO position paper, November 2011. Wkly Epidemiol Rec 2011, 86(Nov (47)):521-539.
10. Girard M.P., Preziosi M.P., Aguado M.T., Kieny M.P. A review of vaccine research and development: meningococcal disease. Vaccine 2006, 24(May (22)):4692-4700.
11. LaForce F.M., Okwo-Bele J.M. Eliminating epidemic group A meningococcal meningitis in Africa through a new vaccine. Health Aff (Millwood) 2011, 30(June (6)):1049-1057.
12. LaForce F.M., Konde K., Viviani S., Preziosi M.P. The meningitis vaccine project. Vaccine 2007, 25(Suppl (1)):A97-A100.
13. Frasch C., Preziosi M.P., LaForce F.M. Development of a group A meningococcal conjugate vaccine, MenAfriVac™. Hum Vaccin Immunother 2012, 8(June (6)).
14. Kim S.H., Pezzoli L., Yacouba H., Coulibaly T., Djingarey M.H., Perea W.A., et al. Whom and where are we not vaccinating? Coverage after the introduction of a new conjugate vaccine against group A meningococcus in Niger in 2010. PLoS One 2012, 7(1):e29116.
15. Pezzoli L., Andrews N., Ronveaux O. Clustered lot quality assurance sampling to assess immunisation coverage: increasing rapidity and maintaining precision. Trop Med Int Health 2010, 15(May (5)):540-546.
16. Bennett S., Woods T., Liyanage W.M., Smith D.L. A simplified general method for cluster-sample surveys of health in developing countries. World Health Stat Q 1991, 44(3):98-106.
17. Pezzoli L., Conteh I., Kamara W., et al. Intervene before leaving: clustered lot quality assurance sampling to monitor vaccination coverage at health district level before the end of a yellow fever and measles vaccination campaign in Sierra Leone in 2009. BMC Public Health 2012, 12:415.
18. World Health Organization Immunization coverage cluster survey - reference manual 2005, World Health Organization, Geneva.
19. Luman E.T., Worku A., Berhane Y., Martin R., Cairns L. Comparison of two survey methodologies to assess vaccination coverage. Int J Epidemiol 2007, 36(June (3)):633-641.
20. Wittig R., König K., Schmidt M., Szarzynski J. A study of climate change and anthropogenic impacts in West Africa. Environ Sci Pollut Res Int 2007, 14(May (3)):182-189.
21. Biemer P.B., Clover R.D. Constructing the survey weights. Sampling of populations methods and applications 2008, 489-516. Wiley, New York. R.M. Groves, G. Kalton, J.N.K. Rao, N. Schwarz, C. Skinner (Eds.).
22. Katz J., Zeger S.L. Estimation of design effects in cluster surveys. Ann Epidemiol 1994, 4(July (4)):295-301.
23. Tadesse H., Deribew A., Woldie M. Predictors of defaulting from completion of child immunization in south Ethiopia, May 2008: a case control study. BMC Public Health 2009, 9:150.
24. Odusanya O.O., Alufohai E.F., Meurice F.P., Ahonkhai V.I. Determinants of vaccination coverage in rural Nigeria. BMC Public Health 2008, 8(November):381.
25. Vaahtera M., Kulmala T., Maleta K., Cullinan T., Salin M.L., Ashorn P. Childhood immunization in rural Malawi: time of administration and predictors of non-compliance. Ann Trop Paediatr 2000, 20(December (4)):305-312.
26. Matsumura T., Nakayama T., Okamoto S., Ito H. Measles vaccine coverage and factors related to uncompleted vaccination among 18-month-old and 36-month-old children in Kyoto, Japan. BMC Public Health 2005, 5(June):59.
27. Stampi S., Ricci R., Ruffilli I., Zanetti F. Compulsory and recommended vaccination in Italy: evaluation of coverage and non-compliance between 1998-2002 in Northern Italy. BMC Public Health 2005, 5(April):42.
28. Alfredsson R., Svensson E., Trollfors B., Borres M.P. Why do parents hesitate to vaccinate their children against measles, mumps and rubella?. Acta Paediatr 2004, 93(September (9)):1232-1237.
29. Trotter C.L., Gay N.J., Edmunds W.J. Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination. Am J Epidemiol 2005, 162(July (1)):89-100.
30. Kinlin L.M., Jamieson F., Brown E.M., Brown S., Rawte P., Dolman S., et al. Rapid identification of herd effects with the introduction of serogroup C meningococcal conjugate vaccine in Ontario, Canada, 2000-2006. Vaccine 2009, 27(March (11)):1735-1740.
31. Maiden M.C., Ibarz-Pavon A.B., Urwin R., Gray S.J., Andrews N.J., Clarke S.C., et al. Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity. J Infect Dis 2008, 197(March (5)):737-743.
32. Salleras L., Dominguez A., Prats G., Parron I., Muñoz P. Dramatic decline of serogroup C meningococcal disease incidence in Catalonia (Spain) 24 months after a mass vaccination programme of children and young people. J Epidemiol Commun H 2001, 55(April (4)):283-287.
33. Centre de Recherche Médicale et Sanitaire Rapport de surveillance microbiologique des méningites au Niger - Season 2011 and summary 2003-2011 2012, Niamey, Niger.
34. Pezzoli L., Tchio R., Dzossa A.D., et al. Clustered lot quality assurance sampling: a tool to monitor immunization coverage rapidly during a national yellow fever and polio vaccination campaign in Cameroon, May 2009. Epidemiol Infect 2011, 22(March):1-13.
35. Greenland K., Rondy M., Chevez A., et al. Clustered lot quality assurance sampling: a pragmatic tool for timely assessment of vaccination coverage. Trop Med Int Health April 2011.